About this event

  • Date and time Tue 8 Nov 2022 from 5:30pm to 7:45pm
  • Location Royal Society of Medicine
  • Organised by Psychiatry

Join us in this meeting to gain an in depth understanding of the effects of Cannabis which is essential for future study and everyday practice. The psychopathology linked to the use of Cannabis, especially high potency Cannabis, has immediate and long term deleterious effects. This meeting will focus on the research leading up to our current understanding of the effects of Cannabis, evidence based prevention and treatment measures as applied in the specialist Cannabis Clinic for Patients with Psychosis. 

The purpose of this meeting is to provide attendees with up to date research on the use of cannabis. Exploring the following questions: Is Cannabis safe? What are the main physiological and mental effects? What is the related psychopathology? How are young people affected?

Research into the use of Cannabis and its effect on health has been pioneered by Professor Robin Murray. Dr Di Forti has set up the Cannabis Clinic for Patients with Psychosis, a specialist clinic changing the lives of people struggling with psychosis due to high potency Cannabis use.

Benefits of attending

  • Learn how Cannabis use manifests itself, especially in young people. Reference to the research will enable participants to gain an evidence-based perspective on the latest thinking about the use of Cannabis in this age group.
  • Attendees will receive a description of the establishment and work of the Cannabis Clinic for Patients with Psychosis, enabling them to translate the research findings into practice and apply models of care to their local needs.

The speakers are nationally and internationally renowned specialists in the study of psychotic disorders at the Kings College London Institute of Psychiatry, Psychology & Neuroscience at the Social, Genetic & the Developmental Psychiatry (SGDP) Centre  Department of Child & Adolescent Psychiatry, and Department of Psychology.

 

Follow us on: 
Facebook 
Instagram
LinkedIn
Twitter 
YouTube 

Show Virtual / In Person rates

Tickets (In Person)

Standard pricing available until 07 November 2022.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£46.00 £27.00 £27.00 £27.00 £14.00

Non - Member

Consultant / GP / SAS Doctors AHP / Nurse / Midwife Trainee Student
£84.00 £50.00 £50.00 £26.00

Tickets (Virtual)

Standard pricing available until 07 November 2022.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£44.00 £26.00 £26.00 £26.00 £14.00

Non - Member

Consultant / GP / SAS Doctors AHP / Nurse / Midwife Trainee Student
£80.00 £47.00 £47.00 £25.00

Key speakers

Sir Robin Murray

Professor of Psychiatric Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London

Speaker's biography

Sir Robin Murray is Professor of Psychiatric Research at the Institute of Psychiatry, London. He was one of the first to suggest that schizophrenia was in part a neurodevelopmental disorder, and he has contributed to the understanding that environmental factors such as obstetric events, drug abuse and social adversity increase the risk of psychosis. He is the most frequently cited psychosis researcher outside the USA, has supervised 80 PhDs and 12 MD Theses, and 40 of his students have become full professors. He was elected a Fellow of the Royal Society in 2010 and received a knighthood in 2011.

Dr Marta Di Forti

Clinical Reader in Psychosis Research, Department of Social, Developmental and Genetic Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London and Honorary Consultant Adult Psychiatrist, Lambeth EI Community Team, South London and Maudsley NHS Foundation Trust

Speaker's biography

Dr Marta Di Forti is a Clinical Reader in Psychosis Research at the Dept of Social, Developmental and Genetic Research, Institute of Psychiatry, and Honorary Consultant Adult Psychiatrist, Lambeth EI Community team, South London and Maudsley NHS Foundation Trust. She leads the first Cannabis Clinic for patients with Psychotic disorders in UK. She was recently awarded the Royal College of Psychiatrist Researcher of the year prize.  In 2020 she was granted a MRC Senior Research Fellowship to expand her research in the role of cannabis use in psychosis and its underlying biology. With her team she showed for the first time that use of high potency types of cannabis e.g. "skunk" carries a higher risk of psychosis than use of traditional types and that it affects rates of Psychotic disorders across Europe. Though it still remains unclear who are those cannabis use most at risk.

Agenda

View the programme (In Person)

Registration, tea and coffee
Welcome and introduction

Dr Gordana Milavić, President, Psychiatry Section, Royal Society of Medicine  

Reefer madness

Sir Robin Murray, Professor of Psychiatric Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London

The cannabis clinic for patients with psychosis

Dr Marta Di Forti, Clinical Reader in Psychosis Research, Department of Social, Developmental and Genetic Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London and Honorary Consultant Adult Psychiatrist, Lambeth EI Community Team, South London and Maudsley NHS Foundation Trust

Questions and answers
Close of meeting
View the programme (Virtual)

Welcome and introduction

Dr Gordana Milavić, President, Psychiatry Section, Royal Society of Medicine

Reefer madness

Sir Robin Murray, Professor of Psychiatric Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London

The cannabis clinic for patients with psychosis

Dr Marta Di Forti, Clinical Reader in Psychosis Research, Department of Social, Developmental and Genetic Research, Institute of Psychiatry, Psychology and Neuroscience, King's College London and Honorary Consultant Adult Psychiatrist, Lambeth EI Community Team, South London and Maudsley NHS Foundation Trust

Questions and answers
Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

 

Registration for this event will close on Monday 7 November 2022 at 00:00. Late registrations will not be accepted.

The agenda is subject to change at any time.

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

We are only able to share presentations that we have received permission to share. This is at the presenter and the RSM’s discretion.